Nabriva Therapeutics plc - Ordinary Shares (NBRV)
Nabriva Therapeutics plc - Ordinary Shares (NBRV)
$2.21 USD
Updated Aug 19 12:00am
Add NBRV to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
NBRV Stock Chart More Charts
NBRV Price/Volume Stats
| Current price | $2.21 |
| Prev. close | $2.28 |
| Day low | $1.66 |
| Day high | $2.45 |
| 50-day MA | $2.28 |
| 200-day MA | $2.24 |
| 52-week high | $3.27 |
| 52-week low | $1.12 |
| Volume | 7,324,100 |
| Avg. volume | 972,444 |
| Dividend yield | N/A |
| Market Cap | 1.62B |
Nabriva Therapeutics plc - Ordinary Shares (NBRV) Company Bio
Nabriva is a clinical-stage biopharmaceutical company engaged in the research and development of novel antibiotics to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company was founded in 2006 and is based in Wien, Austria.
Top Stories View All
Best & Worst Performing Stock Industries for August 19, 2019
Best & Worst Performing Small Cap Stocks for August 19, 2019
Best & Worst Performing Large Cap Stocks for August 19, 2019
Best & Worst Performing Mid Cap Stocks for August 19, 2019
Best & Worst Performing Mega Cap Stocks for August 19, 2019
View All Top Stories
Loading social stream, please wait...